Switch to Abobotulinum toxin A may be useful in the treatment of neurogenic detrusor overactivity when intradetrusor injections of Onabotulinum toxin A failed

摘要

AimsTo assess the outcomes of switching to a different brand of botulinum toxin A (BTA, from Botox (R) to Dysport (R)) in case of failure of intradetrusor injections (IDI) of Botox (R) in the treatment of neurogenic detrusor overactivity (NDO).